From treatment to healing

Towards safe, effective and accessible
psychedelic therapies in Europe

“From a medical care perspective, it is particularly difficult to accept that people continue to suffer because of no or inadequate availability, or the lack of affordability of internationally controlled substances for medical purposes in reliable pharmaceutical quality”.

European Union Statement, Meeting of the UN CND, Vienna, 2020

PSYCHEDELIC ACCESS AND RESEARCH EUROPEAN ALLIANCE - PAREA

We come together to raise awareness, provide evidence-based policy recommendations and accelerate scientific and policy response, leading to the adoption of a holistic approach to psychedelic novel treatments in Europe.

 

Together, we advocate for stepping up European Union’s efforts to thoroughly assess the medicinal benefits of psychedelic compounds as safe, effective, and cost-efficient therapies as well as to better understand and mitigate associated risks. We believe that unlocking the therapeutic potential of psychedelic novel treatments can help millions of Europeans who are in need of better treatment options.

Our Vision

A world in which brain health is valued, preventable suffering is avoided,
and psychedelic treatments help people to heal
and enhance their sense of wellbeing.

Our Members

ecl.png
beckley.png
ebc.png
ecnp.png
https://www.efna.net/
rectangle no bkgrd.png
drugscience.png
Gamian.png
Open-600px (2).png
PsyPAN_logo_highres_smaller (Large).png
PAE logo.png
MIND Foundation Logo_RGB_RGB-Main-Medium (1).png
Norrsken Logo_Full_Black.png

Associate Members and Observers

Associate Member
ICEERS.jpg

Latest News

News
Welcoming Francisca Silva to the PAREA team
Welcoming Francisca Silva to the PAREA team

We’re thrilled to welcome Francisca Silva to the PAREA team, joining us as a Project Officer! A neuroscientist by training, Francisca brings a wealth of knowledge and a genuine passion for brain health and mental well-being. Her interdisciplinary academic background includes a dual MSc in Brain and Mind Sciences from University College London (UCL) and Sorbonne Université, along with a BSc from the Maastricht Science Programme…

Read More →
PAREA issues commentary on EU's high-level expert report: recommendations for prioritizing mental health funding and support
PAREA issues commentary on EU's high-level expert report: recommendations for prioritizing mental health funding and support

PAREA has issued a commentary in response to a recent high-level expert report commissioned by the European Commission, which outlines strategic recommendations for the future of the EU’s R&I Framework Programme. The report underscores the need for increased funding and prioritization of critical societal challenges like mental health, which is increasingly affecting Europeans but remains underfunded and under-researched.

Read More →
PAREA Founder discusses mental health challenges and policy opportunities on TVP World
PAREA Founder discusses mental health challenges and policy opportunities on TVP World

Recently, PAREA’s Founder was interviewed by TVP World, discussing the challenges and policy opportunities in mental health. The interview highlighted the need to move beyond a purely biomedical approach, emphasizing that mental health issues differ fundamentally from typical physical diseases. Watch the interview on YouTube

Read More →
PAREA co-signs EU4Health open letter to European Commission President
PAREA co-signs EU4Health open letter to European Commission President

As a member of the EU4Health Civil Society Alliance, PAREA co-signed an open letter addressed to European Commission President Ursula von der Leyen, raising concerns about the priority given to health within the EU’s agenda. The letter follows the announcement of Commissioners-designate and emphasizes the importance of having a Commissioner with relevant expertise to address health policy adequately.

Read More →
Advocating for mental health innovation: PAREA’s push in Brussels
Advocating for mental health innovation: PAREA’s push in Brussels

In September, PAREA engaged with key European institutions to build political support for mental health and psychedelic therapies. Following the recent EU elections, we see fresh opportunities to re-engage with the European Parliament, Commission, and Council. 

Read More →
PsychedeliCare initiative registered by the European Commission
PsychedeliCare initiative registered by the European Commission

The PsychedeliCare European Citizens’ Initiative has been officially registered by the European Commission.

The European Citizens' Initiative is a mechanism that allows EU citizens to propose new legislation by gathering one million signatures from at least seven EU Member States, prompting the European Commission to consider and potentially act on the initiative.

Read More →